| 摘要 |
<P>PROBLEM TO BE SOLVED: To obtain an oral liquid formulation for allergic rhinitis easily taken and sufficiently stable by solving problems that Schizonepeta herb which is a crude drug conventionally used as a solid formulation gives precipitation when added to the liquid formulation in an effective amount, therefore, it is difficult to provide as a commercial product, and a liquid formulation mixed with a crude drug, Magnoliae Flos, in an effective amount is difficult to provide as a commercial product caused by its inherited unpleasant taste. <P>SOLUTION: The oral liquid formulation composition contains 0.08-1.7 W/V% Magnoliae Flos and 0.08-2.5 W/V% Schizonepeta herb based on the raw crude drug. <P>COPYRIGHT: (C)2004,JPO |
